3A Rare Look into New Guidances: The Future State of Orphan Drug Development, Upcoming Webinar Hosted by Xtalks
Summary
Register for this webinar to explore how the rare disease landscape is changing with guidance from AI, accelerated approval pathways and fostering DEI in clinical research. Post this Register for this webinar to explore how the rare disease landscape is changing with guidance from AI, accelerated approval pathways and fostering DEI in clinical research. Join experts from Premier Research, Adam Bloomfield, MD, FAAP, Vice President, General Medicine, Rare Disease and Pediatrics, Medical Affairs; Leslie Wetherell, Executive Director, Program Strategy, Rare Disease and Pediatrics; Paulla Dennis, Executive Director, Program Strategy, Rare Disease, Pediatrics, Cell and Gene Therapy, for the live webinar on Tuesday, February 25, 2025, at 11am EST (4pm GMT/UK). For more information, or to register for this event, visit A Rare Look into New Guidances: The Future State of Orphan Drug Development. Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities.